Caitlin John’s Novartis NVS Stock Holding History

Caitlin John's NVS Position: Q1 2026 in Review

Caitlin John increased its Novartis (NVS) stake by 15% in Q1 2026, buying an estimated $1.38K and bringing the position to 71 shares worth $10.9K. The position accounts for 0.01% of the portfolio, ranked #512.

Caitlin John first reported a position in NVS in Q4 2023 and has held it in 8 quarters since. The position peaked at $12.5K in Q4 2023. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

• Caitlin John held 71 shares of Novartis worth $10.9K as of Q1 2026.
• Caitlin John bought 9 Novartis shares in Q1 2026, an estimated $1.38K.
• Novartis made up 0.01% of Caitlin John's portfolio in Q1 2026, its #512 holding.
• Caitlin John first reported a position in Novartis in Q4 2023 and has held it in 8 quarters since.
• Caitlin John's Novartis position peaked at $12.5K in Q4 2023.
• 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.